Good and bad sides of viruses in Type 1 diabetes

Author： Filippi Christophe M   von Herrath Matthias G  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.4, Iss.5, 2009-09, pp. : 407-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review

By Pulla Venkat Koushik   Battu Madhu Babu   Alvala Mallika   Sriram Dharmarajan   Yogeeswari Perumal  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 819-832

Informa Healthcare

Access to resources Recommend Favorite

Liraglutide looking good in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Liraglutide "good value for money" in type 2 diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Gene therapy for Type 1 diabetes

By Fenjves E.S.   Ricordi C.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 325-331

Informa Healthcare

Access to resources Recommend Favorite

Brittle Type 1 Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 14, Iss. 16, 2007-07 ,pp. : 1739-1744

Bentham Science Publishers

Access to resources Recommend Favorite